https://thegbm.com/denali-therapeutics-announces-topline-results-for-regimen-g-evaluating-eif2b-agonist-dnl343-in-the-phase-2-3-healey-als-platform-trial/ Business news, opinion, reviews, interviews Mon, 06 Jan 2025 21:30:00 +0000 hourly 1 https://wordpress.org/?v=6.7.1